Effects of Donepezil on Extrapyramidal Symptoms in Patients with Dementia with Lewy Bodies: A Secondary Pooled Analysis of Two Randomized-Controlled and Two Open-Label Long-Term Extension Studies

By  

Dementia and Geriatric Cognitive Disorders, Vol. 40, Iss. 3-4, 2015-07 ,pp. : 186-198

Karger

Access to resources Recommend Favorite

Effects of Donepezil on Central Processing Speed and Attentional Measures in Parkinson’s Disease with Dementia and Dementia with Lewy Bodies

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 3, 2006-12 ,pp. : 161-167

Karger

Access to resources Recommend Favorite

The Effects of an Uninterrupted Switch from Donepezil to Galantamine without Dose Titration on Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 4, Iss. 2, 2014-05 ,pp. : 131-139

Karger

Access to resources Recommend Favorite

The Efficacy of Licensed-Indication Use of Donepezil and Memantine Monotherapies for Treating Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease: Systematic Review and Meta-Analysis

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-07 ,pp. : 212-227

Karger

Access to resources Recommend Favorite

Long-Term Safety and Efficacy of Donepezil in Patients with Dementia with Lewy Bodies: Results from a 52-Week, Open-Label, Multicenter Extension Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 36, Iss. 3-4, 2013-08 ,pp. : 229-241

Karger

Access to resources Recommend Favorite